Researchers from the Mayo Clinic and other institutions conducted a study to determine the feasibility and efficacy of circulating tumor DNA (ctDNA) profiling for the diagnosis of pancreatic ductal adenocarcinoma.
Utilizing Liquid Biopsy to Diagnose Pancreatic Cancer
Jordan Litaker2021-03-16T11:00:51+00:00March 16th, 2021|Pancreatic Cancer Newsletter|Comments Off on Utilizing Liquid Biopsy to Diagnose Pancreatic Cancer